See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A supercharged HIV vaccine could offer strong protection with just one ...

After decades of research, there is still no cure for the disease HIV causes–AIDS. Each year, HIV infects more than one million people worldwide, and a vaccine remains stubbornly out of reach. Hope, ...

Researchers at La Jolla Institute for Immunology, Scripps Research, and the Ragon Institute of MGH, MIT, and Harvard report coordinated studies showing that several HIV germline-targeting immunogens ...

For years, researchers have been hoping for vaccines that protect people against not just one strain of HIV, but every strain of the quickly mutating virus. This requires a vaccine that coaxes the ...

For decades, vaccination has been strongly associated with the prevention and priming of the immune system to protect against future infections. Although this principle still holds, the concept has ...

Solving HIV vaccination—a puzzle that scientists have been tackling for decades without success—could be like cracking the code to a safe. The key, they now think, may be delivering a series of ...

There is still no cure or effective vaccine for HIV-1, which remains a public health threat. But scientists have opened up new possibilities in HIV treatment and vaccine development. A Step Towards a ...

HIV remains a major global public health challenge. Nowhere is this more evident than in southern and eastern Africa, where the majority of people living with HIV reside. Here new HIV infections ...

HIV destroys the immune system from within. Despite decades of research, there still isn’t a vaccine against the virus. The shape-shifting pathogen rapidly adapts to vaccines and renders them useless.

The first PrEPVacc volunteer participant receives an injection at the launch of the launch of the PrePVacc Trial at the Masaka site of the MRC/UVRI and LSHTM Uganda Research Unit, on Tuesday 15 ...